Security key
000899104
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 9,372,549
- Total 13F value
- $47,987,000
- Share change
- -103,729
- SEC-reported price per share
- $5.12
- Number of holders
- 17
- Value change
- -$550,899
- Number of buys
- 4
- Number of sells
- 7
- Shares outstanding
- 238,388,839
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2016
Institutions
17
Top holders
10
ADMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2017
Previous quarter: Q3 2016
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Ownership snapshot
Top reported holders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Aisling Capital LLC
Disclosed value leader
Aisling Capital LLC
Comparable rows
15/15
Latest evidence
30 Sep 2016
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
Aisling Capital LLC leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Aisling Capital LLC's linked filing trail.
Comparable ownership
Top 5
Aisling Capital LLC
1.5%
Biomark Capital Management Co. LLC
0.6%
Consonance Capital Management LP
0.53%
Broadfin Capital, LLC
0.47%
PERCEPTIVE ADVISORS LLC
0.31%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
Company
|
1.5%
|
$26,159,000
3,608,171 shares
|
— | 30 Sep 2016 |
| Biomark Capital Management Co. LLC |
13F
Company
|
0.6%
|
$10,377,000
1,433,304 shares
|
— | 30 Sep 2016 |
| Consonance Capital Management LP |
13F
Company
|
0.53%
|
$9,223,000
1,273,933 shares
|
— | 30 Sep 2016 |
| Broadfin Capital, LLC |
13F
Company
|
0.47%
|
$8,060,000
1,113,293 shares
|
— | 30 Sep 2016 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.31%
|
$5,327,000
734,793 shares
|
— | 30 Sep 2016 |
| FMR LLC |
13F
Company
|
0.18%
|
$3,067,000
423,100 shares
|
— | 30 Sep 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
9,372,549
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
18
Q4 2016 holders
17
Holder diff
-1
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 value | Q4 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend